MML Investors Services’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35M Buy
66,457
+11,872
+22% +$351K ﹤0.01% 1431
2026
Q1
$1.51M Sell
54,585
-16,965
-24% -$436K ﹤0.01% 1482
2025
Q4
$1.55M Buy
+71,550
New +$1.41M ﹤0.01% 1525
2024
Q3
Sell
-30,894
Closed -$327K 2622
2024
Q2
$327K Buy
30,894
+3,329
+12% +$36.5K ﹤0.01% 2033
2024
Q1
$291K Buy
27,565
+855
+3% +$9.22K ﹤0.01% 2126
2023
Q4
$300K Buy
26,710
+10,863
+69% +$106K ﹤0.01% 2044
2023
Q3
$185K Buy
+15,847
New +$179K ﹤0.01% 2172

Other funds holding ROIV

MML Investors Services's ROIV Position: Q2 2026 in Review

MML Investors Services increased its Roivant Sciences (ROIV) stake by 22% in Q2 2026, buying an estimated $351K and bringing the position to 66,457 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

MML Investors Services first reported a position in ROIV in Q3 2023 and has held it in 7 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • MML Investors Services held 66,457 shares of Roivant Sciences worth $2.35M as of Q2 2026.
  • MML Investors Services bought 11,872 Roivant Sciences shares in Q2 2026, an estimated $351K.
  • Roivant Sciences made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1431 holding.
  • MML Investors Services first reported a position in Roivant Sciences in Q3 2023 and has held it in 7 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.